Recombinant human tissue kallikrein
DM199-2021-001
Phase 3 small_molecule active
Quick answer
Recombinant human tissue kallikrein for Acute Stroke is a Phase 3 program (small_molecule) at DiaMedica Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- DiaMedica Therapeutics
- Indication
- Acute Stroke
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active